Erloglob 150mg Tablet

Introduction

Erloglob is a prescription medication that contains the active ingredient Erlotinib. It is available in tablet form and is commonly used to treat certain types of cancer.

Uses

Erloglob is primarily prescribed for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer that has spread to other parts of the body. It is used in combination with other medications or treatments as determined by your healthcare provider.

Dosage and Administration

The dosage of Erloglob will vary depending on your specific condition and medical history. Follow your healthcare provider’s instructions regarding the dosage and duration of treatment.

Erloglob is usually taken once a day, with or without food. It is recommended to take the tablet at the same time each day to maintain a consistent level of the medication in your body. Swallow the tablet whole with a glass of water, and do not crush or chew it.

Mechanism of Action

Erlotinib, the active ingredient in Erloglob, belongs to a class of medications called tyrosine kinase inhibitors. It works by blocking the action of specific proteins that are involved in the growth and spread of cancer cells. By inhibiting these proteins, Erloglob helps to slow down or stop the growth of cancer cells in the body.

Side Effects

Common side effects may include rash, diarrhea, nausea, vomiting, loss of appetite, and fatigue. Note that not all patients will experience these side effects, and they may vary in severity.

Serious side effects of Erloglob may include severe allergic reactions, severe diarrhea, difficulty breathing, and liver problems. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

Erloglob may interact with other medications, including over-the-counter drugs, vitamins, and herbal supplements. Inform your healthcare provider about all the medications you are currently taking to avoid potential drug interactions.

Common drug interactions with Erloglob include medications that affect liver enzymes, such as rifampin, phenytoin, and St. John’s wort. These medications can reduce the effectiveness of Erloglob or increase the risk of side effects. Your healthcare provider will monitor your medication regimen closely to minimize the risk of drug interactions.

Precautions

Before starting Erloglob, inform your healthcare provider about any pre-existing medical conditions, including liver problems, kidney problems, and any allergies you may have. This medication may not be suitable for everyone, and your healthcare provider will assess your individual circumstances and determine if Erloglob is appropriate for you.

Erloglob is contraindicated in pregnant women, as it may cause harm to the developing fetus. Use effective contraception during treatment with Erloglob and for a period of time after discontinuing the medication.

Storage

Erloglob should be stored at room temperature, away from moisture and heat. Keep the medication in its original packaging and out of reach of children. Do not use Erloglob if the expiration date has passed.

Patient Tips

• take Erloglob exactly as prescribed by your healthcare provider. Do not change the dosage or stop taking the medication without consulting your healthcare provider.
• If you experience any new or worsening symptoms while taking Erloglob, such as persistent cough, difficulty breathing, or severe abdominal pain, notify your healthcare provider immediately.
• Regular follow-up appointments with your healthcare provider are important to monitor your response to treatment and manage any potential side effects.
• maintain a healthy lifestyle during treatment with Erloglob, including a balanced diet and regular exercise. Your healthcare provider may also recommend additional supportive care measures to help manage side effects.
• If you have any questions or concerns about Erloglob or your treatment plan, do not hesitate to reach out to your healthcare provider for clarification and guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Mastocytosis – Treatment (NHS UK) [Accessed 26 Jun. 2024] (online) Available at:
• Erlotinib 100 mg film-coated tablets (Health Professionals SmPC) Available at:
• Erlotinib (Drugs.com) [Accessed 3 Jun. 2024] (online) Available at:
• erlotinib 150 mg tablet antineoplastic – protein-tyrosine kinase inhibitors (RX) [Accessed 0 Jun. 2024] (online) Available at:
• Erlotinib (MedlinePlus) [Accessed 1 Jun. 2024] (online) Available at:
• Abdelgalil AA, Al-Kahtani HM, Al-Jenoobi FI. Erlotinib. Profiles Drug Subst Excip Relat Methodol. 2020;45:93-117. doi: 10.1016/bs.podrm.2019.10.004. Epub 2019 Dec 6. [Accessed 5 Jun. 2024] Available at: